Who is sponsoring NCT04190017?

NCT04190017 is sponsored by Ankara City Hospital Bilkent.

What drugs are being tested in NCT04190017?

Interventions in NCT04190017: Cranial MRI.

What condition does NCT04190017 study?

NCT04190017 studies Central Nervous System Vulnerabilities in Preterm Infants.

Is NCT04190017 still recruiting?

NCT04190017 is currently status unknown. Last updated 13 January 2021.

Last reviewed 2021-01-13 · How we verify

NCT04190017

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Brain Volumes Measured by 2D USG and MRI

Status unknown Last updated 13 January 2021

What this trial tests

trial testing Cranial MRI in Central Nervous System Vulnerabilities in Preterm Infants in 25 participants. Status unknown.

Timeline

1 November 2019

Primary endpoint
30 December 2021

30 March 2022

Quick facts

Lead sponsor	Ankara City Hospital Bilkent
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	25
Start date	1 November 2019
Primary completion	30 December 2021
Estimated completion	30 March 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Cranial MRI

Conditions studied

Central Nervous System Vulnerabilities in Preterm Infants — all drugs for Central Nervous System Vulnerabilities in Preterm Infants →

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 1 Day to 3 Months, any sex, with Central Nervous System Vulnerabilities in Preterm Infants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cranial USG is simple and easy method to assess preterm infant brain. Some studies showed that brain volumes of preterm infants could be calculated by measurement of 2D distances. Our aim in this study was to compare brain volume obtained by USG and MRI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04190017 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
Last refreshed: 13 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04190017.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing